A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial.
Teng ZhuYu-Hong HuangWei LiCan-Gui WuYi-Min ZhangXing-Xing ZhengTing-Feng ZhangYing-Yi LinZai-Yi LiuGuo-Lin YeYing LinZhi-Yong WuKun WangPublished in: British journal of cancer (2024)
The clinical trial numbers were NCT03154749 and NCT04858529.
Keyphrases
- neoadjuvant chemotherapy
- artificial intelligence
- clinical trial
- double blind
- lymph node
- locally advanced
- sentinel lymph node
- machine learning
- big data
- deep learning
- phase ii
- open label
- study protocol
- phase iii
- rectal cancer
- cross sectional
- placebo controlled
- squamous cell carcinoma
- randomized controlled trial
- young adults